Tokyo, Japan

Ikuya Seki

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Chiba, JP (1998)
  • Ichihara, JP (1998)
  • Sodegaura, JP (2007 - 2010)
  • Tokyo, JP (2013 - 2018)

Company Filing History:


Years Active: 1998-2018

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Ikuya Seki: Innovator in Radiopharmaceuticals

Introduction

Ikuya Seki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of radiopharmaceuticals, holding a total of nine patents. His work focuses on developing innovative compounds that have potential applications in medical imaging and treatment.

Latest Patents

Among his latest patents is a radioactive iodine-labeled pyrido[1,2-a]benzoimidazole derivative compound. This invention relates to a compound represented by a specific general formula or a salt thereof, which can be utilized in radiopharmaceuticals. Another notable patent is for a radioactive halogen-labeled pyrido[1,2-a]benzimidazole derivative compound. This invention also pertains to a compound represented by a specific general formula or a salt thereof, intended for use in radiopharmaceuticals.

Career Highlights

Ikuya Seki has worked with notable organizations such as Nihon Medi-Physics Company, Limited and Kyoto University. His experience in these institutions has allowed him to advance his research and development in the field of radiopharmaceuticals.

Collaborations

He has collaborated with esteemed colleagues, including Yoshifumi Shirakami and Hideo Saji. These partnerships have contributed to the success of his innovative projects.

Conclusion

Ikuya Seki's work in the field of radiopharmaceuticals showcases his dedication to advancing medical science through innovation. His patents reflect a commitment to developing compounds that can significantly impact healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…